Adrenal insufficiency is a rare, chronic and potentially fatal disease, caused by the inability of the adrenal glands to produce sufficient amounts of cortisol, a hormone critical for the correct functioning of the body. From the 3rd of March 2014, Italian patients suffering from this disease, have access to a new treatment: modified-release hydrocortisone, that reproduces the natural variations in the body during the day.
Adrenal insufficiency is a rare, chronic and potentially fatal disease, caused by the inability of the adrenal glands to produce sufficient amounts of cortisol, a hormone critical for the correct functioning of the body. From the 3rd of March 2014, Italian patients suffering from this disease, have access to a new treatment: modified-release hydrocortisone, that reproduces the natural variations in the body during the day.
full press conference
Introduction - Moderator Carlo Gargiulo
What is adrenal insufficiency and which the causes
Symptoms
The new therapy
Specification of the new therapy - 1^
Specification of the new therapy - 2^
Specification of the new therapy - 3^
Patient's point of view - Dr. Lorenzo Sala, Vicepresident A.I.P.Ad
Patients' expectations - Dr. Lorenzo Sala, Vicepresident A.I.P.Ad
A.I.P.Ad Mission and Activities - Dr. Lorenzo Sala, Vicepresident
Conclusion - Moderator Carlo Gargiulo
highlights
The association - Dr. Lorenzo Sala, Vicepresident
A small book of great importance - Dr. Lorenzo Sala, Vicepresident A.I.P.Ad
The new drug: the opion of A.I.P.Ad, Dr. Lorenzo Sala, Vicepresident
A drug for a better quality of life
A disorder not east to diagnose
Viropharma and its mission - Dr. Carlo Sabato, GM Viropharma
Engineered biotecnology for the patient - Dr. Carlo Sabato GM Viropharma
